Status UnknownBusiness

Biomedical Translation Fund

Australian Government · Australia

The Biomedical Translation Fund is an Australian Government program that invests through private fund managers in promising biomedical innovations, such as OncoRes Medical’s digital imaging technology to improve breast cancer surgery outcomes.

Official Grant Page

Location

Australia

Who Can Apply

Formal eligibility criteria are not provided on this case study page. The fund supports Australian biomedical innovations and medical device companies. Investment is made via private fund managers such as Brandon Capital. Projects are expected to deliver significant health and economic benefits in Australia.
This page is a case study describing how Brandon Capital, as one of the private fund managers of the Biomedical Translation Fund, invested in and helped establish OncoRes Medical in 2016. It does not provide formal eligibility criteria for applicants. It indicates that the fund supports Australian biomedical innovations and companies developing medical devices and technologies with strong potential health and economic benefits, but specific requirements, entity types, or application processes are not described here.

What's Funded

Equity investment via private fund managers into biomedical companies to develop and commercialise innovative medical devices, technologies and related research outcomes in Australia.

Expected Outcomes

Retention and commercialisation of Australian biomedical innovations, development of new medical technologies, and improved health and economic outcomes such as better breast cancer surgery results.

Key Information

Funding Purposes

r_and_dcommercialisationresearch

Keywords

Biomedical Translation FundBTFBrandon CapitalOncoRes Medicalbreast cancermedical devicedigital imagingbiomedical

Frequently Asked Questions

What is the Biomedical Translation Fund?

The Biomedical Translation Fund is a business grant offered by Australian Government in Australia. The Biomedical Translation Fund is an Australian Government program that invests through private fund managers in promising biomedical innovations, such as OncoRes Medical’s digital imaging technology to improve breast cancer surgery outcomes.

Who is eligible for the Biomedical Translation Fund?

Formal eligibility criteria are not provided on this case study page. The fund supports Australian biomedical innovations and medical device companies. Investment is made via private fund managers such as Brandon Capital. Projects are expected to deliver significant health and economic benefits in Australia.

What activities are funded?

Equity investment via private fund managers into biomedical companies to develop and commercialise innovative medical devices, technologies and related research outcomes in Australia.

How do I apply for the Biomedical Translation Fund?

Start by checking your eligibility using the free Beta Docs eligibility checker. If eligible, Beta Docs' AI-powered platform can help you draft, review, and refine your application to maximise your chances of success.

Need help applying?

Beta Docs has helped founders secure $160M+ in competitive grants. Our AI platform drafts compliance-perfect applications — and our expert reviewers make sure you stand out.

Start with Beta DocsBook a free consultation